- Home
- Our Providers
Natural Aesthetics
- Telehealth
- Publications
starstarstarstarstar
4.9 stars | 133 reviews
- Home
- Our Providers
Natural Aesthetics
- Telehealth
- Publications
Renew Specialty Group is committed to helping you achieve your fullest potential. Our
personalized approach utilizes advanced GLP-1 medications to support effective and sustainable weight loss, as well as improved metabolic health. With our expert guidance and customized treatment plans, you can embark on your journey toward reaching your health and wellness goals.
Schedule a complimentary consultation today to start your path to a healthier weight
and lifestyle.
Semaglutide is a GLP-1 receptor agonist designed to support weight management and blood sugar control. It mimics the action of the natural hormone glucagon-like peptide-1 (GLP-1), which plays a key role in regulating appetite and glucose levels. By activating\ GLP-1 receptors, Semaglutide helps to reduce hunger, increase feelings of fullness, and slow down gastric emptying. This results in decreased calorie intake and improved weight loss. Additionally, Semaglutide enhances insulin secretion and lowers glucagon levels, which contributes to overall metabolic health.
Semaglutide is a GLP-1 receptor agonist, which means it mimics the natural hormone glucagon-like peptide-1 (GLP-1). It binds to GLP-1 receptors in the brain, helping to reduce appetite and increase feelings of fullness. By slowing down gastric emptying, Semaglutide injections for weight loss further decrease hunger and help control food intake. Additionally, it enhances insulin secretion and reduces glucagon production, leading to more stable blood sugar levels. This comprehensive approach supports effective weight management and improves metabolic health, contributing to sustained weight loss. Loss.
Semaglutide dosage at Renew ranges from .25mg - 2.4mg.
The amount of weight you can lose with Semaglutide varies based on several factors, including your starting weight, adherence to the treatment plan, and individual metabolic response. Clinical studies have demonstrated that patients using Semaglutide can achieve an average weight loss of 10-15% of their body weight over a period of several months.
Tirzepatide is a groundbreaking medication that combines the effects of GLP-1 (glucagon-like peptide-1) and GIP (gastric inhibitory polypeptide) receptor agonists. This dual-action approach helps regulate appetite and improve blood sugar control. By activating both GLP-1 and GIP receptors, Tirzepatide leads to reduced hunger, increased feelings of fullness, and slower gastric emptying. These mechanisms contribute to decreased calorie intake and effective weight loss. Additionally, Tirzepatide supports insulin secretion and helps stabilize blood glucose levels.
Tirzepatide weight loss injections act as a dual-action agonist by targeting both GLP-1 (glucagon-like peptide-1) and GIP (gastric inhibitory polypeptide) receptors. When these receptors are activated, Tirzepatide enhances insulin secretion, lowers glucagon levels, and slows gastric emptying. As a result, it leads to reduced appetite and increased feelings of fullness. The combined effects of activating GLP-1 and GIP receptors improve blood sugar control and facilitate effective weight loss.
Tirzepatide dosage at Renew ranges from 1mg-15mg.
Tirzepatide has shown significant promise in weight management. On average, individuals using Tirzepatide can achieve a weight reduction of approximately 15-20% of their initial body weight over several months. Combining Tirzepatide with a balanced diet and regular exercise can enhance weight loss results and support long-term success.
Retatrutide is a next-generation weight loss medication that goes beyond current options like semaglutide (Ozempic/Wegovy) and Tirzepatide (Mounjaro/Zepbound). What sets it apart is its triple-action approach, targeting three key hormone receptors—GLP-1, GIP, and glucagon—to address hunger, metabolism, and energy expenditure all at once. This unique mechanism has led to unprecedented weight loss results in clinical trials, while also showing a greater ability to preserve lean muscle mass compared to other GLP-1-based medications. Additionally, Retatrutide may help reduce systemic inflammation, further supporting overall metabolic health and long-term wellness.
Retatrutide is a triple hormone receptor agonist, meaning it activates three hormones involved in regulating hunger, metabolism, and energy use—GLP-1, GIP, and glucagon. This combination helps reduce appetite, improve insulin function, and increase the number of calories your body burns, leading to greater weight loss than single-hormone therapies.
In clinical trials, patients lost up to 24.2% of their body weight over 48 weeks, with some individuals losing 50 to 60 pounds or more. These results are among the most impressive seen in any obesity medication to date, surpassing the outcomes from currently available GLP-1 or GIP/GLP-1 treatments.
Vitamin injections are a direct method of delivering essential nutrients into your bloodstream. By bypassing the digestive system, these injections ensure that vitamins like MIC B12 and SUPER B COMPLEX are absorbed more efficiently and quickly. This helps address deficiencies and supports energy levels, metabolism, and overall health. The injections work by replenishing vital nutrients that may be lacking in your diet, leading to improved vitality, mood, and physical performance. Regular vitamin injections can help you achieve and maintain optimal health and well-being.
The goal of any weight loss program should be to maximize benefits while minimizing side effects. The goal is not to race to the highest dose as quickly as possible. Finding a dose that works well for you and leads to steady, healthy, weight loss is.
Hormonal imbalances, underactive thyroid, gut permeability, and chronic stress can all cause weight loss resistance. Getting to the root cause is essential for success and long-term maintenance. Renew also offers hormone therapy for both women and men.
Most weight loss clinics do not offer a maintenance program, which is key to long-term success. Renew's maintenance program includes a low dose of GLP-1 medication which will keep you at your goal weight and provide many other health benefits.
The obesity epidemic is a growing concern, affecting even our youth. Childhood obesity can lead to serious health issues like depression, cardiovascular disease, and increased cancer risk. Thankfully, GLP-1 medications offer a safe and effective solution for those 12 and up.
Want to know if you're a good candidate for GLP-1 medications? Call Renew Specialty Group at (704) 612-0011 or fill out the form below. We look forward to helping you achieve all your health goals!
